Xanodyne Pharmaceuticals Inc

-

Fund Information and Directors

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Xanodyne Pharmaceuticals Inc
Firm
Fund #
CIK #0001335480
Sale2009-05-15 ($87.8 M Offered, $87.8 M Sold)
Fund
Phone8593717581
AddressOne Riverfront Place
Newport, 41071
Source [EDGAR]
Fund AUM and Sold ($M)
907254361802008201020132016
Fund Details
Director
Custodian
Auditor
Marketer
Broker
Jurisdiction
Directors2011 - 2025
Vaughan Kailian
Stephen St Peter
Stephen Stamp
Timothy Arendt
Steven St Peter
Thomas Jennings
Craig Tooman
Natasha Giordano
James Shannon
Peter Wentworth
Dennis Purcell
Kevin Anderson
Rolf Classon
Michael Valentino
Gary Shangold
Daniel Docherty
Rita OConnor
Vaughn Kailian
Patrick Enright
Comparable Firms State AUM ($B)
10001 Innovation Partners, LLC
0.0
1005 LCC
0.0
100 Edgewood Holdings, LLC
0.0
100 Thieves CC, LLC
0.0
100 Thieves, LLC
0.0
100x LP
0.0
Infineon Technologies AG
0.0
Infinity Cross TIE & RAIL Inc
0.0
Infinity Exploration LLC
0.0
01 Advisors 01, L.P.
0.0
Terms | Privacy | Guide
tony@aum13f.com